Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes

Details for Australian Patent Application No. 2009314191 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Biftu, Tesfaye; Chen, Ping; Cox, Jason M.; Weber, Ann E.

Agent Spruson & Ferguson

Pub. Number AU-B-2009314191

PCT Pub. Number WO2010/056708

Priority 61/199,179 13.11.08 US

Filing date 11 November 2009

Wipo publication date 20 May 2010

Acceptance publication date 16 February 2012

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/4162 (2006.01) - condensed with heterocyclic ring systems

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

26 May 2011 PCT application entered the National Phase

  PCT publication WO2010/056708 Priority application(s): WO2010/056708

16 February 2012 Application Accepted

  Published as AU-B-2009314191

14 June 2012 Standard Patent Sealed

11 October 2012 Alteration of Name

  The name of the patentee has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009314192-Eimeria vaccine for turkeys

2009314186-Fluoropolymer compositions and treated substrates